Clinical Trial Update: CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 Diabetes Mellitus (T2DM) in India

View source ↗

Summary

CAPTIVATE India has completed. The study assessed the prevalence of cardiovascular disease among individuals with Type 2 diabetes mellitus in India.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED